CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40

被引:545
作者
ALDERSON, MR
ARMITAGE, RJ
TOUGH, TW
STROCKBINE, L
FANSLOW, WC
SPRIGGS, MK
机构
[1] IMMUNEX RES & DEV CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101
[2] IMMUNEX RES & DEV CORP,DEPT IMMUNOBIOL,SEATTLE,WA 98101
关键词
D O I
10.1084/jem.178.2.669
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD40 is a member of the tumor necrosis factor (TNF) receptor family of cell surface proteins and was originally described as a B cell restricted antigen. Treatment of primary human monocytes with granulocyte/macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3), or interferon gamma (IFN-gamma) resulted in the induction of CD40 mRNA and enhancement of cell surface protein expression. CD40 was found to mediate monocyte adhesion to cells expressing recombinant CD40 ligand. CD40 ligand-transfected cells provided a potent costimulus for monocyte TNF-alpha and IL-6 production in the presence of GM-CSF, IL-3, or IFN-gamma, and enhanced IL-8 production stimulated by GM-CSF or IL-3. In addition, CD40 ligand-transfected cells acting in the absence of a costimulus induced monocytes to become tumoricidal against a human melanoma cell target. Collectively, these data indicate that CD40 ligand is pleiotropic with potent biological activity on monocytes.
引用
收藏
页码:669 / 674
页数:6
相关论文
共 28 条
[1]  
ALDERSON MR, 1992, J IMMUNOL, V149, P1252
[2]   INTERLEUKIN-7 INDUCES CYTOKINE SECRETION AND TUMORICIDAL ACTIVITY BY HUMAN PERIPHERAL-BLOOD MONOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
ZIEGLER, SF ;
GRABSTEIN, KH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :923-930
[3]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[4]  
AVAROGRACIA JM, 1989, J EXP MED, V170, P865
[5]   SOLUBLE CD23 IS RELEASED BY B-LYMPHOCYTES CYCLING IN RESPONSE TO INTERLEUKIN-4 AND ANTI-BP50 (CDW40) [J].
CAIRNS, J ;
FLORESROMO, L ;
MILLSUM, MJ ;
GUY, GR ;
GILLIS, S ;
LEDBETTER, JA ;
GORDON, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (03) :349-353
[6]  
ELLIOTT MJ, 1990, J IMMUNOL, V145, P167
[7]  
FANSLOW WC, 1992, J IMMUNOL, V149, P655
[8]  
FRENDL G, 1990, J IMMUNOL, V144, P3400
[9]  
GALY AHM, 1992, J IMMUNOL, V149, P775
[10]  
GORDON J, 1988, J IMMUNOL, V140, P1425